Vimarsana
Biggest News Aggregation in the World

Page 44 - Oral Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oral Solution Today - Breaking & Trending Today

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update - Vimarsana News

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update News provided by Share this article NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million, a 26.5% increase over the prior year period. The company also recorded an additional $500,000 in revenue during the first quarter associated with divested product rights for two brands...

Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Exclusive Report by MarketsandMarkets - Vimarsana News

Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Exclusive Report by MarketsandMarkets

Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Exclusive Report by MarketsandMarkets "Companion Animal Pharmaceuticals Market by Indication (Infectious Diseases, Antibiotics, Parasiticides, Vaccines, Pain), Animal Type (Dogs, Cats, Horses), Distribution Channel (Veterinary Hospitals & Clinics), COVID-19 Impact - Global Forecast to 2026", published by MarketsandMarkets, the global market is projected to reach USD 18.5 billion by 2026 from USD 12.8 billion in 2021, at a CAGR of 7.6% during the forecast period. Browse in-depth TOC on "Companion Animal Pharmaceuticals Mark...

Stocks in the news: Ashok Leyland, GCPL, Vedanta, DRL, Tanla Platforms and YES Bank - Vimarsana News

Stocks in the news: Ashok Leyland, GCPL, Vedanta, DRL, Tanla Platforms and YES Bank

Explore Now Nifty futures on the Singapore Exchange traded 56.50 points, or 0.38 per cent, higher at 14,920 in signs that Dalal Street was headed for a positive start on Thursday. Here are a few stocks which may buzz the most in today's trade: Ashok Leyland: Commercial vehicles major Ashok Leyland on Wednesday said it has decided to form two new subsidiaries as part of its plans to strengthen green transport solutions.The first unit is being formed to carry on the electric vehicle strategy in India and forms part of its global entity. The second subsidiary will focus on providing mobility as...

Stocks in news: Vedanta, Jindal Steel, Bharti Airtel, Dixon Tech and more - Vimarsana News

Stocks in news: Vedanta, Jindal Steel, Bharti Airtel, Dixon Tech and more

Stocks in news: Vedanta, Jindal Steel, Bharti Airtel, Dixon Tech and more Stocks to watch out for on April 8: Vedanta, Jindal Steel & Power, Bharti Airtel, Dixon Technologies, Godrej Consumer Products and more BusinessToday.In | April 8, 2021 | Updated 09:39 IST Stocks to watch today: Vedanta, Jindal Steel & Power, Bharti Airtel, Dixon Technologies, Godrej Consumer Products Sensex and Nifty are likely to open in the green today as SGX Nifty was trading with a gain of 69.50 points or 0.47 percent. Nifty Futures were trading around 14,933 on the Singapore exchange. On Wednesday,  benchmark ...

Dr. Reddy's launches generic version of Kuvan in U.S. - Vimarsana News

Dr. Reddy's launches generic version of Kuvan in U.S.

Updated: Share Article AAA Dr. Reddy’s Laboratories has unveiled Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg, a therapeutic equivalent generic version of Kuvan (sapropterin dihydrochloride) Powder for Oral Solution, 100 mg, USP, in the U.S. Indicated for the treatment of Phenylketonuria, it has been launched following approval from the U.S. Food and Drug Administration. (USFDA). CEO (North America Generics) Marc Kikuchi said the company is committed to bring affordable generic medicines. Also, “this product demonstrates that we are actively expanding the breadth of our ...